Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Oriana Simonetti, Giulia Radi, Elisa Molinelli, Giulio Rizzetto, Federico Diotallevi & Annamaria Offidani. (2021) Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management. Human Vaccines & Immunotherapeutics 17:10, pages 3268-3275.
Read now
Read now
Julia A. Tree, Graham Hall, Peter Rees, Julia Vipond, Simon G. P. Funnell & Allen D. Roberts. (2016) Repeated high-dose (5 × 108 TCID50) toxicity study of a third generation smallpox vaccine (IMVAMUNE) in New Zealand white rabbits. Human Vaccines & Immunotherapeutics 12:7, pages 1795-1801.
Read now
Read now
Enrico D'Amelio, Simonetta Salemi & Raffaele D'Amelio. (2016) Anti-Infectious Human Vaccination in Historical Perspective. International Reviews of Immunology 35:3, pages 260-290.
Read now
Read now
Articles from other publishers (28)
Edgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, Erika Menius, Katrin Nopora, Jane Maclennan & Heinz Weidenthaler. (2023) A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults. Vaccine 41:2, pages 397-406.
Crossref
Crossref
Olga Chervyakova, Aisha Issabek, Kulyaisan Sultankulova, Arailym Bopi, Nurlan Kozhabergenov, Zamira Omarova, Ali Tulendibayev, Nurdos Aubakir & Mukhit Orynbayev. (2022) Lumpy Skin Disease Virus with Four Knocked Out Genes Was Attenuated In Vivo and Protects Cattle from Infection. Vaccines 10:10, pages 1705.
Crossref
Crossref
Edgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, Erika Menius, Katrin Nopora, Jane Maclennan & Heinz Weidenthaler. (2022) A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults. SSRN Electronic Journal.
Crossref
Crossref
Heeji Lim, Hyun Ju In, You-Jin Kim, Sundong Jang, Yun Ha Lee, Su Hwan Kim, Sun Hwa Lee, Jun Hyuk Park, Hyo Jin Yang, Jung-Sik Yoo, Sang-Won Lee, Mi Young Kim, Gyung Tae Chung & Sang Gu Yeo. (2021) Development of an attenuated smallpox vaccine candidate: The KVAC103 strain. Vaccine 39:36, pages 5214-5223.
Crossref
Crossref
Andrew T. Russo, Aklile Berhanu, Catherine B. Bigger, Jon Prigge, Peter M. Silvera, Douglas W. Grosenbach & Dennis Hruby. (2020) Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge. Vaccine 38:3, pages 644-654.
Crossref
Crossref
Anne Monette & Andrew J. Mouland. 2019. Biology of T Cells - Part B. Biology of T Cells - Part B
175
263
.
Silvia Ratto-Kim, In-Kyu Yoon, Robert M. Paris, Jean-Louis Excler, Jerome H. Kim & Robert J. O’Connell. (2018) The US Military Commitment to Vaccine Development: A Century of Successes and Challenges. Frontiers in Immunology 9.
Crossref
Crossref
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves & M.J.T. Carrondo. 2017. Comprehensive Biotechnology. Comprehensive Biotechnology
633
656
.
Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton, Thomas C. Marbury, Eva Wagner, Eva Kreitmeir, Siegfried Röesch, Alfred von Krempelhuber, Philip Young, Richard Nichols, Thomas P. Meyer, Darja Schmidt, Josef Weigl, Garth Virgin, Nathaly Arndtz-Wiedemann & Paul Chaplin. (2016) A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects. PLOS ONE 11:6, pages e0157335.
Crossref
Crossref
Richard N Greenberg, Yadira Hurley, Dinh V. Dinh, Serena Mraz, Javier Gomez Vera, Dorothea von Bredow, Alfred von Krempelhuber, Siegfried Roesch, Garth Virgin, Nathaly Arndtz-Wiedemann, Thomas Peter Meyer, Darja Schmidt, Richard Nichols, Philip Young & Paul Chaplin. (2015) A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis. PLOS ONE 10:10, pages e0138348.
Crossref
Crossref
Richard B. Kennedy, Inna G. Ovsyannikova, V. Shane Pankratz, Iana H. Haralambieva, Robert A. Vierkant, Robert M. Jacobson & Gregory A. Poland. (2012) Genome-wide genetic associations with IFNγ response to smallpox vaccine. Human Genetics 131:9, pages 1433-1451.
Crossref
Crossref
Laura Serino, Kate L. Seib & Mariagrazia Pizza. 2012. Innovation in Vaccinology. Innovation in Vaccinology
3
15
.
J. S. Kennedy, M. Gurwith, C. L. Dekker, S. E. Frey, K. M. Edwards, J. Kenner, M. Lock, C. Empig, S. Morikawa, M. Saijo, H. Yokote, K. Karem, I. Damon, M. Perlroth & R. N. Greenberg. (2011) Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults. Journal of Infectious Diseases 204:9, pages 1395-1402.
Crossref
Crossref
Roberto Rosini, Michèle A. Barocchi & Rino Rappuoli. 2011. Development of Vaccines. Development of Vaccines
1
18
.
António Roldão, Tiago Vicente, Cristina Peixoto, Manuel J.T. Carrondo & Paula M. Alves. (2011) Quality control and analytical methods for baculovirus-based products. Journal of Invertebrate Pathology 107, pages S94-S105.
Crossref
Crossref
Thary Jacob, Céline Van den Broeke & Herman W. Favoreel. (2011) Viral Serine/Threonine Protein Kinases. Journal of Virology 85:3, pages 1158-1173.
Crossref
Crossref
Sharone Green, Francis A. Ennis & Anuja Mathew. (2011) Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines. Vaccine 29:8, pages 1666-1676.
Crossref
Crossref
A. Roldão, A.C. Silva, M.C.M. Mellado, P.M. Alves & M.J.T. Carrondo. 2011. Comprehensive Biotechnology. Comprehensive Biotechnology
625
649
.
Aklile Berhanu, David S. King, Stacie Mosier, Robert Jordan, Kevin F. Jones, Dennis E. Hruby & Douglas W. Grosenbach. (2010) Impact of ST-246® on ACAM2000™ smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice. Vaccine 29:2, pages 289-303.
Crossref
Crossref
Troy D. Querec & Bali Pulendran. 2010. The Immune Response to Infection. The Immune Response to Infection
547
557
.
Margaret E. Fairman-Williams & Eckhard Jankowsky. 2010. RNA Helicases. RNA Helicases
168
188
.
Eric M. Bachelder, Tristan T. Beaudette, Kyle E. Broaders, Jean M. J. Fréchet, Mark T. Albrecht, Alfred J. Mateczun, Kristy M. Ainslie, John T. Pesce & Andrea M. Keane-Myers. (2010) In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants. Molecular Pharmaceutics 7:3, pages 826-835.
Crossref
Crossref
Austin L. Hughes, Stephanie Irausquin & Robert Friedman. (2010) The evolutionary biology of poxviruses. Infection, Genetics and Evolution 10:1, pages 50-59.
Crossref
Crossref
Andrew W. Artenstein. 2010. Vaccines: A Biography. Vaccines: A Biography
9
29
.
Jay W. Hooper, Anthony M. Ferro, Joseph W. Golden, Peter Silvera, Jeanne Dudek, Kim Alterson, Max Custer, Bryan Rivers, John Morris, Gary Owens, Jonathan F. Smith & Kurt I. Kamrud. (2009) Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 28:2, pages 494-511.
Crossref
Crossref
Richard B. Kennedy, Inna Ovsyannikova & Gregory A. Poland. (2009) Smallpox vaccines for biodefense. Vaccine 27, pages D73-D79.
Crossref
Crossref
Andrew. W. Artenstein. (2009) Vaccines for military use. Vaccine 27, pages D16-D22.
Crossref
Crossref
Richard B Kennedy, Inna G Ovsyannikova, Robert M Jacobson & Gregory A Poland. (2009) The immunology of smallpox vaccines. Current Opinion in Immunology 21:3, pages 314-320.
Crossref
Crossref